BioCentury
ARTICLE | Financial News

Sirnaomics raises $25M series C1 round

June 7, 2018 9:16 PM UTC

Sirnaomics Inc. (Gaithersburg, Md.) raised $25 million in an untranched series C1 round led by Yuexiu New Industrial Investment. Fellow new investors Sangel Biomedical Venture Capital, HuaKong Equity Investment and Qianhai Shenghui Investment also participated.

Sirnaomics' lead product STP705 is a histidine-lysine polymer (HKP) nanoparticle encapsulation of siRNAs targeting transforming growth factor (TGF) beta 1 (TGFB1) and cyclooxygenase-2 (COX-2). The candidate is in a Phase IIa trial to treat hypertrophic scars...

BCIQ Company Profiles

Sirnaomics Ltd.